All In MedTech

Device Trial Radar · NCT05806203

A Study of Participants Ages 21-65 Diagnosed With Dyspareunia and the Effects of Low Intensity Shockwave Treatment

Randomized Controlled Trial for Use of Low Intensity Shockwave for Patients With Dyspareunia

Last checked: Nov 20, 2026Latest source record: Nov 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Aug 15, 2023

Primary completion

Apr 1, 2024

Study completion Apr 30, 2024

Sponsor

Lead sponsor
SoftWave Tissue Regeneration TechnologiesNot on our public-company list
Sponsor type
Industry
First posted
Apr 10, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 21 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Dyspareunia is defined as a complaint of persistent or recurring pain or discomfort associated with attempted or complete vaginal penetration e purpose of this study is to determine the effectiveness of low intensity shockwave treatment for patients with dyspareunia and their ability to tolerate sexual activity, (i.e., penetration of vagina, self or partnered pleasure). Participants will: * Be given a preliminary physical therapy examination and evaluation. * Be asked to attend weekly low intensity shockwave treatment visits. * Be asked to complete 3 Month follow up questionnaires

Conditions

  • Female Dyspareunia

Interventions

  • Low intensity shockwave treatment to pelvic floor region plus typical physical therapyDevice

    Treatment dose: 1,000 - 1,500 shocks, 2.5-3.0 Hz, 0.06-0.10 mJ/mm2 (Intensity of 6-8), 8 to 12 minutes

  • Sham shockwave treatment plus typical physical therapyDevice

    Inactive dose of shockwave treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tampon TestTime frame: up to 6 weeks

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • New You Health and Wellness

    Wauwatosa, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.